Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kiniksa Pharmaceuticals Ltd
KNSACurrent price
20.21 USD
-0.32 USD (-1.58%)
Last closed
20.28 USD
Company
www.kiniksa.com
ISIN
BMG5269C1010
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
1 491 748 480 USD
Yield for 12 month
+18.22 %
1Y
3Y
5Y
10Y
15Y
KNSA
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-387, an investigational, that is in Phase 2/3 clinical trial for human immunoglobulin G2 monoclonal antibody that binds human interleukin-1 receptor 1, inhibiting IL-1a, IL-1ß-mediated signaling for the treatment of advance recurrent pericarditis by providing the added convenience of monthly subcutaneous dosing with a liquid formulation. Its preclinical products include KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody. The company was formerly known as Kiniksa Pharmaceuticals, Ltd and changed its name tpKiniksa Pharmaceuticals International, plc in June 2024. The company was incorporated in 2015 and is based in London, the United Kingdom. Address: 23 Old Bond Street, London, United Kingdom, WIS 4PZ
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
35.57 USDP/E ratio
–Dividend Yield
–Current Year
+423 239 000 USD
Last Year
+270 259 000 USD
Current Quarter
+122 536 000 USD
Last Quarter
+112 214 000 USD
Current Year
+423 239 000 USD
Last Year
+213 735 000 USD
Current Quarter
+184 762 000 USD
Last Quarter
+62 798 000 USD
Key Figures KNSA
1 year
3 years
5 years
10 years
EBITDA
-43 921 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-5.15 %
PEG Ratio
–
Return On Equity TTM
-9.85 %
Wall Street Target Price
35.57 USD
Revenue TTM
423 239 008 USD
Book Value
6.05 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
46.90 %
Dividend Yield
–
Gross Profit TTM
234 018 000 USD
Earnings per share
-0.60 USD
Diluted Eps TTM
-0.60 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
550.00 %
Profit Margin
-10.21 %
Dividend Analytics KNSA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History KNSA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:1
Payout Ratio
–
Last Split Date
28.06.2024
Stock Valuation KNSA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
2.97
Price Sales TTM
3.52
Enterprise Value EBITDA
-44.93
Price Book MRQ
3.40
Financials KNSA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators KNSA
For 52 weeks
16.87 USD
28.15 USD
50 Day MA
21.04 USD
Shares Short Prior Month
3 072 555
200 Day MA
22.51 USD
Short Ratio
4.66
Shares Short
3 129 716
Short Percent
9.56 %
BeatStart